Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |